Vorschau! Die Detailseite für diese Publikation wurde nicht aktiviert!
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α
mehr| Titel | Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α |
|---|---|
| Medien | Clinical Cancer Research |
| Heft | 12 |
| Band | 26 |
| Verfasser | James N. Ingle, Junmei Cairns, Vera Suman, Lois E. Shepherd , Peter A. Fasching, Tanya L. Hoskin, Ravinder J. Singh, Desta Zeruesenay, Krishna R. Kalari, Matthew J. Ellis, Paul E. Goss, Bingshu E. Chen, Prof. Dr. Bernhard Volz, Poulami Barman, Erin E. Carlson, Tufia Haddad, Matthew P. Goetz, Barbara Goodnature, Matthew Cuellar, Michael A. Walters, Cristina Correia |
| Seiten | 2986-2996 |
| Veröffentlichungsdatum | 31.07.2020 |
| Zitation | Ingle, James N.; Cairns, Junmei; Suman, Vera; Shepherd , Lois E.; Fasching, Peter A.; Hoskin, Tanya L.; Singh, Ravinder J.; Zeruesenay, Desta; Kalari, Krishna R.; Ellis, Matthew J.; Goss, Paul E.; Chen, Bingshu E.; Volz, Bernhard; Barman, Poulami; Carlson, Erin E.; Haddad, Tufia; Goetz, Matthew P.; Goodnature, Barbara; Cuellar, Matthew; Walters, Michael A.; Correia, Cristina (2020): Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α. Clinical Cancer Research 26 (12), 2986-2996. |